Lancet study finds no benefit for hydroxychloroquine in COVID-19 patients

Boston, May 22: Treatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study. The research, published in the journal The Lancet,

Read more: https://www.oneindia.com/india/lancet-st...

Actual news in your location


Similar news

BJP MP Sakshi Maharaj put under 14-day quarantine; BJP threatens agitation if not freed immediately 0 0 0
Delhi L-G gives nod to hold JEE, NEET exams in city 0 0 0
Delhi Metro to resume services from Sep 7 in calibrated manner: DMRC 0 0 0
BJP MP Sakshi Maharaj put under 14-day quarantine; BJP threatens agitation if not freed immediately 0 0 0
Delhi L-G gives nod to hold JEE, NEET exams in city 0 0 0
Delhi Metro to resume services from Sep 7 in calibrated manner: DMRC 0 0 0
Coronavirus: India may see 4.92 lakh deaths by December 1, reveals US study 0 0 666
Bengal’s COVID-19 recovery rate crosses 80 per cent 0 0 666
COVID-19 impact: Canadian economy contracts in 2nd quarter; GDP dips 38.7% 0 0 666
Rebooting Economy XXII: Why is India reluctant to provide unemployment allowance? 0 0 666